CDKN2A and melanoma: Similarly, Shain et al. [8] used multi-region sequencing of melanomas and their precursor lesions to show a stepwise accumulation of somatic mutations, highlighting the sequential inactivation of CDKN2A and disruption of pathways such as p53 and SWI/SNF as critical to tumor evolution.